1. Global Status of Emerging Lophomonas Infection: A Systematic Review of Reported Cases (1993—2020)
   Maryam Nakhaei et al, 2022, Interdisciplinary Perspectives on Infectious Diseases CrossRef
2. Serum NSE is Early Marker of Transformed Neuroendocrine Tumor After EGFR-TKI Treatment of Lung Adenocarcinoma
   Xiaowei Mao et al, 2022, Cancer Management and Research CrossRef
3. Lophomoniasis broncopulmonar: a propósito de varios casos y revisión de la literatura
   Wesley Cardona Castro et al, 2024, Acta Colombiana de Cuidado Intensivo CrossRef
4. Glycoproteins and Cancer Biomarkers
   Md Abedul Haque, 2023, Current Cancer Biomarkers CrossRef
5. Transformation to small cell lung cancer after first-line afatinib treatment
   Takayuki Shiroyama et al, 2018, Respiratory Medicine Case Reports CrossRef
6. Histological Transformation to Small Cell Carcinoma of an Adenosquamous Carcinoma of the Lung With Epidermal Growth Factor Receptor Mutation in Exons 20 and 21 After Treatment With Erlotinib: Case Report
   Liliana Fernández-Trujillo et al, 2019, Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine CrossRef
7. Small-cell lung cancer transformation from EGFR-mutant adenocarcinoma after EGFR-TKIs resistance
   Yiqian Jiang et al, 2021, Medicine CrossRef
8. Histomorphological transformation from non-small cell lung carcinoma to small cell lung carcinoma after targeted therapy or immunotherapy: A report of two cases
   Hao Liu et al, 2022, Frontiers in Oncology CrossRef
9. Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression
   Yen-Shou Kuo et al, 2020, Scientific Reports CrossRef
10. Advances in studies of tyrosine kinase inhibitors and their acquired resistance
    Qinlian Jiao et al, 2018, Molecular Cancer CrossRef